Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Johnson & Johnson Innovative Medicine ANZJohnson & Johnson Innovative Medicine ANZ
VS
Alkem Laboratories Ltd.Alkem Laboratories Ltd.
Johnson & Johnson Innovative Medicine ANZ

Johnson & Johnson Innovative Medicine ANZ

1-5 Khartoum Rd, North Ryde, NSW, AU, 2113

Last Update: 04/03/2026

View Profile
756/1000Fair

At Johnson & Johnson Innovative Medicine, we are leading where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confid...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Lower Parel, Alkem House , Mumbai, IN, 400013

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.alkemlabs.com
775/1000Fair

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It wa...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:15,609
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Johnson & Johnson Innovative Medicine ANZ

Johnson & Johnson Innovative Medicine ANZ

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine ANZ in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alkem Laboratories Ltd. in 2026.

Incidents

Incident History - Johnson & Johnson Innovative Medicine ANZ (X = Date, Y = Severity)

Johnson & Johnson Innovative Medicine ANZ cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Alkem Laboratories Ltd. (X = Date, Y = Severity)

Alkem Laboratories Ltd. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Johnson & Johnson Innovative Medicine ANZ

Johnson & Johnson Innovative Medicine ANZ

Incidents
No explicit notable incidents reported.
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Incidents
No explicit notable incidents reported.

FAQ

Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has the best AI Cybersecurity Score ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced more cyber incidents in the past ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced more cyber incidents this year ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced at least one ransomware attack ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced at least one data breach ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced at least one targeted cyberattack ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has experienced at least one vulnerability ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one holds the most compliance certifications ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one holds the fewest compliance certifications ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has the most subsidiaries ?
Between Johnson & Johnson Innovative Medicine ANZ company and Alkem Laboratories Ltd. company, which one has the largest number of employees ?
Between Johnson & Johnson Innovative Medicine ANZ and Alkem Laboratories Ltd., which company holds both SOC 2 Type 1 certifications ?
Between Johnson & Johnson Innovative Medicine ANZ and Alkem Laboratories Ltd., which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Johnson & Johnson Innovative Medicine ANZ or Alkem Laboratories Ltd. ?
Which company is PCI DSS compliant - Johnson & Johnson Innovative Medicine ANZ or Alkem Laboratories Ltd. ?
Between Johnson & Johnson Innovative Medicine ANZ and Alkem Laboratories Ltd., which company complies with HIPAA regulations for healthcare data ?
Between Johnson & Johnson Innovative Medicine ANZ and Alkem Laboratories Ltd., which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-15511
SUMMARY

A vulnerability was determined in Comfast CF-WR631AX V3 up to 2.7.0.8. Affected by this vulnerability is the function system_wl_upload_pic_file of the file /usr/bin/webmgnt of the component FastCGI Backend. This manipulation of the argument filename causes os command injection. It is possible to initiate the attack remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 9.8)
CVSS2
Base Score: 10.0
Complexity: LOW
AV:N/AC:L/Au:N/C:C/I:C/A:C
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-15510
SUMMARY

A vulnerability was found in Leantime up to 3.8.0. Affected is the function Setting::saveSetting of the component API. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15509
SUMMARY

A vulnerability has been found in Leantime up to 3.8.0. This impacts the function editUser/addUser of the component JSON-RPC Endpoint. The manipulation of the argument role leads to improper authorization. The attack is possible to be carried out remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15508
SUMMARY

A flaw has been found in Helicone ai-gateway up to 0.2.0-beta.30. This affects the function build_target_url of the file ai-gateway/src/dispatcher/service.rs of the component AWS Metadata Service. Executing a manipulation of the argument extracted_path_and_query can lead to server-side request forgery. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-15507
SUMMARY

A vulnerability was detected in coollabsio Coolify up to 4.1.1. The impacted element is an unknown function of the file /app/Policies/ of the component Policy Handler. Performing a manipulation results in missing authorization. Remote exploitation of the attack is possible. The exploit is now public and may be used.

PUBLISHED
Date2026-07-12
UPDATED
Date2026-07-12
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8